Introduction: Who Should Undergo Diagnostics

People who should undergo diagnostics for stage 4 colorectal cancer include anyone experiencing concerning symptoms that might indicate the disease has progressed beyond its original location. Even though colon cancer sometimes causes no symptoms even at an advanced stage, many people eventually notice warning signs that require medical attention.^[1]

Common symptoms that should prompt you to seek diagnostic testing include blood in your stool or blood appearing in the toilet after you use the bathroom. This blood might make your stool look dark or bright red, though it’s important to know that blood in stool doesn’t automatically mean cancer. Other concerning changes include persistent alterations in your bowel habits, such as ongoing diarrhea or constipation that doesn’t go away, or feeling like your bowel doesn’t empty completely even after a bowel movement.^[1]

Additional symptoms that warrant diagnostic evaluation include ongoing belly discomfort such as cramps, gas, bloating, or pain that has no clear cause and doesn’t improve. Some people notice they feel full very soon after starting to eat, or they might find a lump in their belly button area. Iron deficiency anemia, which is a condition where your body doesn’t have enough iron-rich red blood cells, can cause tiredness, weakness, and changes in skin color, and may indicate internal bleeding from a tumor.^[1]

When cancer has already spread to other organs, additional symptoms may appear depending on where the disease has traveled. For example, if cancer has spread to the liver, you might experience pain in the upper right part of your belly. If it reaches the lungs, you could have difficulty breathing or a persistent cough.^[1]

Classic Diagnostic Methods

Diagnosing metastatic colorectal cancer requires multiple types of tests and procedures that work together to give doctors a complete picture of your condition. The diagnostic process can take some time because healthcare providers need to not only confirm that cancer is present, but also determine exactly where it has spread and what characteristics it has.^[7]

Physical Examination and Medical History

The diagnostic journey typically begins with a physical examination and a detailed discussion of your medical history. Your doctor will ask about your symptoms, when they started, and how they’ve changed over time. They’ll want to know about your family history of cancer, particularly if any close relatives have had colorectal cancer. During the physical exam, your doctor may perform a digital rectal exam, which involves inserting a gloved finger into your rectum to feel for any abnormalities.^[7]

Blood Tests

Blood tests play an important role in the diagnostic process. One particularly useful blood test measures carcinoembryonic antigen, or CEA for short, which is a protein produced by some colon cancer cells. When CEA levels are high in your blood, this can indicate the presence of colon cancer or show that existing cancer is progressing. However, CEA testing alone cannot diagnose cancer because some people with cancer have normal CEA levels, and some people without cancer have elevated levels.^[10]

Other blood tests can reveal indirect signs of cancer, such as anemia (low red blood cell count) which might result from internal bleeding caused by a tumor. Blood tests also help doctors assess your overall health and how well your organs are functioning, which is important information when planning treatment.^[7]

Colonoscopy and Biopsy

A colonoscopy is one of the most important diagnostic procedures for colorectal cancer. During this examination, a doctor inserts a long, flexible tube with a tiny camera on the end into your rectum and guides it through your entire large intestine. This allows the doctor to look directly at the inside lining of your colon and rectum to search for tumors or abnormal growths.^[7]

If the doctor sees anything suspicious during the colonoscopy, they will perform a biopsy, which means taking a small sample of tissue for laboratory testing. Sometimes the tissue sample can be collected right during the colonoscopy, while other times a separate surgical procedure may be needed to obtain the sample. In the laboratory, specialists examine the tissue under a microscope to determine whether the cells are cancerous, what type of cancer it is, and how aggressive it appears.^[10]

Imaging Tests

Imaging tests create detailed pictures of the inside of your body and are essential for determining whether cancer has spread and where it has traveled. Several types of imaging tests are used to diagnose and stage metastatic colorectal cancer.^[10]

Computed tomography, or CT scans, are the main imaging tests used to detect colon cancer and assess how far it has spread. A CT scan uses X-rays taken from many different angles and combines them with computer processing to create cross-sectional images of your bones, blood vessels, and soft tissues. For stage 4 colorectal cancer diagnosis, doctors typically order CT scans of your chest, abdomen, and pelvis to look for cancer that may have spread to your lungs, liver, or other abdominal organs.^[10]

Magnetic resonance imaging, or MRI, is another important scanning method that uses powerful magnets and radio waves instead of X-rays to create detailed images of your body’s soft tissues. MRI scans are particularly useful for examining the pelvis in cases of rectal cancer. Like CT scans, MRI helps doctors see how far cancer has spread when you’ve already been diagnosed with colorectal cancer.^[10]

A PET scan, which stands for positron emission tomography, may also be helpful in some cases. This type of scan can detect areas of increased metabolic activity in your body, which often indicates the presence of cancer cells. PET scans are particularly useful when doctors need to decide whether surgery is a realistic option for removing cancer that has spread outside the colon.^[10]

For colorectal cancer, doctors also commonly order a chest X-ray to check whether cancer has spread to the lungs, which is one of the most common sites where colorectal cancer travels.^[7]

Molecular and Genetic Testing

Modern diagnosis of stage 4 colorectal cancer goes beyond simply confirming that cancer is present. Doctors now perform sophisticated laboratory tests on cancer cells to identify specific gene changes or mutations that affect how the cancer grows and responds to treatment. This type of testing, called molecular and genetic testing, helps doctors understand the unique characteristics of your particular cancer.^[10]

These genetic features guide treatment decisions because some medicines only work when certain gene changes are present, while other treatments work better when specific mutations are absent. Understanding the molecular profile of your cancer allows your medical team to choose the most effective treatments and avoid those unlikely to help.^[10]

All stage 4 colorectal cancers should be tested for several important biomarkers, which are identifiable characteristics of the cancer that doctors can target with specific therapies. The most important biomarkers that should be tested include mismatch repair deficiency or microsatellite instability (abbreviated as dMMR/MSI-H), RAS mutations (including both KRAS and NRAS), BRAF mutations, and HER2 amplification.^[25]

It’s possible to test for many biomarkers simultaneously using a process called next generation sequencing, or NGS, which can identify some rare biomarkers that may have specific treatments available. These rare biomarkers include POLE/POLD1 mutations, RET fusions, and NTRK fusions.^[25]

Diagnostics for Clinical Trial Qualification

When patients with stage 4 colorectal cancer consider participating in clinical trials, which are research studies testing new treatments, additional diagnostic tests and criteria may be required beyond standard diagnostic procedures. Clinical trials have specific eligibility requirements to ensure that participating patients are appropriate candidates for the experimental treatment being studied.^[3]

Before enrolling in a clinical trial, patients must undergo a comprehensive staging evaluation to confirm they have metastatic disease and to document precisely where the cancer has spread. This typically includes CT scans of the chest, abdomen, and pelvis with contrast enhancement. For rectal cancer specifically, an MRI of the pelvis is usually required. These imaging studies must be recent, often performed within a few weeks before trial enrollment, to ensure the information accurately reflects the current state of the disease.^[18]

Blood tests form another essential component of clinical trial qualification. The CEA blood test mentioned earlier must be performed to establish a baseline level of this tumor marker. Many trials track CEA levels throughout treatment to monitor how well the experimental therapy is working. Additionally, comprehensive blood work assessing liver function, kidney function, and blood cell counts is required to ensure patients are healthy enough to tolerate the trial treatment safely.^[18]

Molecular profiling and biomarker testing take on even greater importance for clinical trial enrollment than for standard treatment. Many modern clinical trials specifically recruit patients whose cancers have particular genetic characteristics. For example, some trials only accept patients whose tumors show mismatch repair deficiency, while others specifically seek patients with certain RAS or BRAF mutations. The trial protocol will clearly specify which biomarkers must be tested and what results are required for eligibility.^[25]

Tissue samples from the original tumor biopsy must typically be available for additional testing when entering a clinical trial. Sometimes trials require a fresh biopsy, meaning a new tissue sample must be obtained specifically for the research study, even if previous biopsy samples exist. This allows researchers to analyze the most current characteristics of the cancer and may help them understand how the disease has changed over time or after previous treatments.^[10]

Lynch syndrome screening is another diagnostic requirement for many colorectal cancer clinical trials. Lynch syndrome is an inherited condition that increases cancer risk, and understanding whether a patient has this genetic syndrome can influence treatment decisions and trial eligibility. This screening is important not only for the patient’s treatment but also for their family members, who may benefit from knowing about potential inherited cancer risk.^[18]

Clinical trials may also require documentation of previous treatments and their outcomes. Patients need detailed medical records showing exactly what treatments they’ve already tried, how long they received each treatment, and how their cancer responded. This information helps researchers understand whether the experimental treatment might offer benefits beyond what standard therapies have already provided.^[3]

Performance status assessment is another standard qualification criterion for clinical trials. Doctors evaluate how well patients can perform daily activities and how cancer symptoms affect their daily life. Many trials only accept patients who are still able to care for themselves and remain reasonably active, as these patients are most likely to tolerate experimental treatments safely. This assessment ensures that participation in the trial won’t place patients at unacceptable risk.^[3]